News

Conestoga Capital Launches New Leadership in Growth Strategies

Conestoga Capital Launches New Leadership in Growth Strategies

Conestoga Capital Advisors Unveils New Succession Plans

Conestoga Capital Advisors, LLC, an independent investment firm, has recently outlined its succession plans for the flagship Small Cap Growth strategy. These strategic changes are set to unfold as Derek Johnston steps into the role of Co-Portfolio Manager, succeeding Joe Monahan in late 2025. This transition is expected to ensure a seamless continuation of investment management that Conestoga has established.

Leadership Transition at Conestoga Capital

Bob Mitchell, Co-Founder and Managing Partner at Conestoga, has expressed confidence in the transition process. He remarked that his long-standing collaboration with Derek on the SMid Cap Growth strategy has formed a strong basis for future joint efforts in managing the Small Cap Growth strategy. Mitchell emphasized the impactful legacy Joe Monahan leaves behind as he approaches retirement in 2026, acknowledging the substantial contributions Joe has made to the firm's success.

Derek Johnston's Journey at Conestoga

Derek Johnston's tenure at Conestoga began in 2015, and his ascension to Co-Portfolio Manager of the SMid Cap Growth strategy in 2016 marked a significant milestone. By becoming a partner in 2018, he showcased his commitment and expertise, significantly contributing to the firm's growth, raising assets from less than $100 million to an impressive nearly $2 billion. As he transitions to Co-Portfolio Manager for the Small Cap Growth strategy and rises to Managing Partner, he is poised to lead with a wealth of experience spanning 29 years.

Educational Accomplishments

Derek holds a Bachelor of Science from Boston College and an MBA from the Marshall School of Business at the University of Southern California. He has been recognized as a Chartered Financial Analyst since 2003. His enthusiasm for Conestoga's culture and commitment to client service reflects a deep-rooted dedication that he aims to carry forward in his new role.

Joe Monahan's Legacy and Future

Joe Monahan, who joined Conestoga in 2008 and has been a pivotal figure in the firm, served both as Co-Portfolio Manager of the Small Cap Growth strategy and as Director of Research. His leadership and insight have been crucial in scaling the firm’s assets under management from under $1 billion to over $8 billion, showcasing his impact on the company's trajectory.

David Neiderer Steps Up

As Monahan transitions away from his positions, David Neiderer will take over as Director of Research and will also be promoted to Managing Partner. David’s contributions since joining in 2013 have been significant, and his background includes a Bachelor of Science in Economics and Accounting from the University of Richmond, along with an MBA from The Wharton School of the University of Pennsylvania. An accomplished CFA Charterholder and CPA, David's skills are expected to elevate the firm’s research capabilities further.

A Bright Future for Conestoga Capital Advisors

Established in 2001 and headquartered in Wayne, Pennsylvania, Conestoga Capital Advisors has built a strong reputation as an independent investment advisory firm. Managing over $8 billion in portfolios across various capital growth categories, the firm focuses on high-quality, conservative growth companies. Its commitment to a disciplined investment approach is evident in its strategy to achieve capital appreciation through fundamental research and a long-term investment outlook.

Frequently Asked Questions

What are the key changes happening in Conestoga Capital Advisors?

Conestoga has announced that Derek Johnston will succeed Joe Monahan as Co-Portfolio Manager for the Small Cap Growth strategy by the end of 2025, with Monahan remaining involved until his retirement.

Who is Derek Johnston and what is his background?

Derek Johnston has been with Conestoga since 2015, previously managing the SMid Cap Growth strategy and has significantly contributed to the firm's asset growth.

What is Joe Monahan's role in the transition?

Joe Monahan will step back from his role as Co-Portfolio Manager after years of significant contributions, while still assisting in a supportive capacity through his retirement in 2026.

Who will replace Joe Monahan as Director of Research?

David Neiderer will assume the role of Director of Research, promoting his leadership within the firm as part of the succession plan.

What is Conestoga Capital Advisors’ focus?

The firm specializes in managing portfolios for institutional and individual investors, prioritizing high-quality, conservative growth investments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading